Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 6 (2), 117-27

Chlamydia Pneumoniae and Atherosclerosis


Chlamydia Pneumoniae and Atherosclerosis

Robert J Belland et al. Cell Microbiol.


Exposure to Chlamydia pneumoniae is extremely common, and respiratory infections occur repeatedly among most people. Strong associations exist between C. pneumoniae infection and atherosclerosis as demonstrated by: (i) sero-epidemiological studies showing that patients with cardiovascular disease have higher titres of anti-C. pneumoniae antibodies compared with control patients; (ii) detection of the organism within atherosclerotic lesions, but not in adjacent normal tissue by immunohistochemistry, polymerase chain reaction and electron microscopy and by culturing the organism from lesions; and (iii) showing that C. pneumoniae can either initiate lesion development or cause exacerbation of lesions in rabbit and mouse animal models respectively. The association of this organism with atherosclerosis has also provided sufficient impetus to conduct a variety of human secondary prevention antibiotic treatment trials. The results of these studies have been mixed and, thus far, no clear long-lasting benefit has emerged from these types of investigations. Studies of C. pneumoniae pathogenesis have shown that the organism can infect many cell types associated with both respiratory and cardiovascular sites, including lung epithelium and resident alveolar macrophages, circulating monocytes, arterial smooth muscle cells and vascular endothelium. Infected cells have been shown to exhibit characteristics associated with the development of cardiovascular disease (e.g. secretion of proinflammatory cytokines and procoagulants by infected endothelial cells and foam cell formation by infected macrophages). More detailed analysis of C. pneumoniae pathogenesis has been aided by the availability of genomic sequence information. Genomic and proteomic analyses of C. pneumoniae infections in relevant cell types will help to define the pathogenic potential of the organism in both respiratory and cardiovascular disease.

Similar articles

  • Chlamydia Pneumoniae and Vascular Disease: An Update
    FF Mussa et al. J Vasc Surg 43 (6), 1301-7. PMID 16765261. - Review
    Exposure to Chlamydia pneumoniae is extremely common, and its incidence increases with age. C pneumoniae infection is strongly associated with coronary artery disease, as …
  • Chlamydia Pneumoniae and Atherosclerosis
    LA Campbell et al. Semin Respir Infect 18 (1), 48-54. PMID 12652454. - Review
    Chlamydia pneumoniae is a human respiratory pathogen that causes acute respiratory disease. Multiple studies have associated C. pneumoniae with cardiovascular disease inc …
  • [The Relationship Between Chlamydia Pneumoniae and Atherosclerosis]
    A Gayet et al. Presse Med 30 (36), 1792-801. PMID 11771205. - Review
    The notion of an association between these two factors is biologically plausible. Several points remain to be clarified, particularly the need to develop a reliable diagn …
  • Chlamydia Pneumoniae--An Infectious Risk Factor for Atherosclerosis?
    LA Campbell et al. Nat Rev Microbiol 2 (1), 23-32. PMID 15035006. - Review
    Cardiovascular disease, of which atherosclerosis is an important component, is the leading cause of death in the western world. Although there are well-defined risk facto …
  • Chlamydia Pneumoniae and Atherosclerosis: Current State and Future Prospectives
    R Sessa et al. Int J Immunopathol Pharmacol 22 (1), 9-14. PMID 19309547. - Review
    Chlamydia pneumoniae, an intracellular bacterial pathogen, is known as a leading cause of human respiratory tract infections worldwide. Over the last decade, several repo …
See all similar articles

Cited by 40 PubMed Central articles

See all "Cited by" articles

LinkOut - more resources